Blade Air Mobility/$BLDE

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Blade Air Mobility

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

Ticker

$BLDE
Primary listing

Industry

Passenger Airlines

Employees

310

ISIN

US0926671043

BLDE Metrics

BasicAdvanced
$336M
-
-$0.34
1.55
-

What the Analysts think about BLDE

Analyst ratings (Buy, Hold, Sell) for Blade Air Mobility stock.

Bulls say / Bears say

Blade Air Mobility's recent partnership with Qatar Airways enables seamless travel from anywhere in the world to Monaco on a single ticket, potentially expanding its customer base and increasing revenue. (globenewswire.com)
The company's asset-light business model, focusing on terminal infrastructure and technology rather than owning aircraft, positions it well for scalability and profitability, especially with the anticipated adoption of electric vertical aircraft (EVA). (seekingalpha.com)
Analysts have set an average price target of $8.17 for BLDE stock, indicating a potential upside of over 150% from current levels, reflecting strong confidence in the company's growth prospects. (nasdaq.com)
Blade Air Mobility reported a net loss of $33.94 million in Q4 2023, more than doubling the loss from the previous year, raising concerns about its path to profitability. (benzinga.com)
The company's revenue growth has been dampened by the decision to discontinue unprofitable activities, which may indicate challenges in sustaining consistent revenue streams. (seekingalpha.com)
Insider selling activity, including the CEO selling 2.1 million shares for approximately $6.76 million, might signal a lack of confidence in the company's near-term prospects. (nasdaq.com)
Data summarised monthly by Lightyear AI. Last updated on 13 Jul 2025.

BLDE Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

BLDE Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $BLDE

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs